Brent Siler

Senior Counsel

I've had the good fortune to assist companies and underwriters with some of the most exciting technology and life science IPOs in recent years.

Brent Siler has experience in representing public companies, soon-to-be-public companies and underwriters. His clients are focused mostly in technology and the life sciences, and he assists them in connection with registered public offerings, private financings, public company securities compliance, corporate governance, M&A and general corporate counseling. Brent has represented issuers and underwriters in more than 75 public offerings, including 50+ IPOs.

Download full bio 


  • Apellis Pharmaceuticals – $402.5 Million Follow-On Offering 

  • MaxCyte – $202 Million IPO 

  • Verve Therapeutics – $307 Million IPO 

  • Werewolf Therapeutics – $120 Million IPO 

  • Instil Bio – $368 Million IPO 

  • View all


  • Harvard Law School
    JD, cum laude, 1986

  • University of Denver
    BA, magna cum laude, 1981

Admissions & Credentials

District of Columbia


Rankings & Accolades

    Chambers USA: Corporate/M&A and Private Equity

    IPO Vital Signs